loadpatents
name:-0.043889999389648
name:-0.0078201293945312
name:-0.021472930908203
Boitano; Anthony Patent Filings

Boitano; Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boitano; Anthony.The latest application filed is for "methods and compositions for treating autoimmune diseases".

Company Profile
21.6.40
  • Boitano; Anthony - Newton MA
  • BOITANO; Anthony - Waban MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods And Compositions For Treating Autoimmune Diseases
App 20220273811 - Gillard; Geoffrey O. ;   et al.
2022-09-01
Anti-cd45 Antibodies And Conjugates Thereof
App 20220267441 - Boitano; Anthony ;   et al.
2022-08-25
T-cell Depleting Therapies
App 20220249683 - Boitano; Anthony ;   et al.
2022-08-11
Anthracycline Antibody-drug Conjugates And Uses Thereof
App 20220226493 - McDonagh; Charlotte Fenton ;   et al.
2022-07-21
Anti-cd117 Antibodies And Uses Thereof
App 20220177575 - Palchaudhuri; Rahul ;   et al.
2022-06-09
Anti-cd117 Antibody Drug Conjugates And Uses Thereof
App 20220177577 - McDonagh; Charlotte Fenton ;   et al.
2022-06-09
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
App 20220175951 - Boitano; Anthony ;   et al.
2022-06-09
Anti-cd117 Antibody-drug Conjugates And Uses Thereof
App 20220175944 - McDonagh; Charlotte F. ;   et al.
2022-06-09
Conditioning Methods For Gene Therapy
App 20220175946 - BOITANO; Anthony ;   et al.
2022-06-09
Anti-cd117 Antibodies And Uses Thereof
App 20220177578 - Palchaudhuri; Rahul ;   et al.
2022-06-09
Dosing Regimens For The Mobilization Of Hematopoietic Stem And Progenitor Cells
App 20220096559 - Morrow; Dwight ;   et al.
2022-03-31
Use Of An Anti-cd45 Antibody Drug Conjugate (adc) In Cell Therapy
App 20220062339 - Cooke; Michael ;   et al.
2022-03-03
Dosing regimens for the mobilization of hematopoietic stem and progenitor cells
Grant 11,260,079 - Morrow , et al. March 1, 2
2022-03-01
Methods For Allogeneic Hematopoietic Stem Cell Transplantation
App 20210379195 - Palchaudhuri; Rahul ;   et al.
2021-12-09
Methods Of Treating Cancer With Aryl Hydrocarbon Receptor Antagonists
App 20210379033 - BOITANO; Anthony
2021-12-09
Anti-cd45 Antibodies And Conjugates Thereof
App 20210371524 - Palchaudhuri; Rahul ;   et al.
2021-12-02
Compositions And Methods For The Depletion Of Cd5+ Cells
App 20210369854 - Boitano; Anthony ;   et al.
2021-12-02
Use Of Anti-cd5 Antibody Drug Conjugate (adc) In Allogeneic Cell Therapy
App 20210355230 - Boitano; Anthony ;   et al.
2021-11-18
Compositions And Methods For The Depletion Of Cd117+ Cells
App 20210317228 - Pearse; Bradley R. ;   et al.
2021-10-14
Therapeutic Methods Using Antibody Drug Conjugates (adcs)
App 20210283267 - Boitano; Anthony ;   et al.
2021-09-16
Use Of An Anti-cd2 Antibody Drug Conjugate (adc) In Allogeneic Cell Therapy
App 20210260212 - Boitano; Anthony ;   et al.
2021-08-26
Use Of Anti-cd137 Antibody Drug Conjugate (adc) In Allogeneic Cell Therapy
App 20210228696 - Boitano; Anthony ;   et al.
2021-07-29
Aryl Hydrocarbon Receptor Antagonists And Methods Of Use
App 20210220408 - BOITANO; Anthony ;   et al.
2021-07-22
Compositions And Methods For The Depletion Of Cd117+ Cells
App 20210206872 - Pearse; Bradley R. ;   et al.
2021-07-08
Compositions And Methods For The Depletion Of Cd134+ Cells
App 20210101990 - Hoban; Megan D. ;   et al.
2021-04-08
Anti-cd252 Antibodies, Conjugates, And Methods Of Use
App 20210095039 - Boitano; Anthony ;   et al.
2021-04-01
Compositions and methods for the depletion of CD117+ cells
Grant 10,899,843 - Pearse , et al. January 26, 2
2021-01-26
Compositions and methods for the depletion of CD117+ cells
Grant 10,882,915 - Pearse , et al. January 5, 2
2021-01-05
Fc Silenced Antibody Drug Conjugates (adcs) And Uses Thereof
App 20200376135 - Boitano; Anthony ;   et al.
2020-12-03
Compositions And Methods For The Depletion Of Cd2+ Cells
App 20200368363 - BOITANO; Anthony ;   et al.
2020-11-26
Compositions And Methods For The Expansion Of Hematopoietic Stem And Progenitor Cells And Treatment Of Inherited Metabolic Disorders
App 20200338132 - BOITANO; Anthony ;   et al.
2020-10-29
Compositions And Methods For The Depletion Of Cd137+ Cells
App 20200289664 - Hartigan; Adam ;   et al.
2020-09-17
Compositions And Methods For The Depletion Of Cd5+ Cells
App 20200276326 - Boitano; Anthony ;   et al.
2020-09-03
Fc Silenced Antibody Drug Conjugates (adcs) And Uses Thereof
App 20200255523 - Kind Code
2020-08-13
Compositions and methods for the depletion of CD137+ cells
Grant 10,576,161 - Hartigan , et al.
2020-03-03
Compositions And Methods For Hematopoietic Stem And Progenitor Cell Transplant Therapy
App 20190343885 - BOITANO; Anthony ;   et al.
2019-11-14
Dosing Regimens For The Mobilization Of Hematopoietic Stem And Progenitor Cells
App 20190336536 - Morrow; Dwight ;   et al.
2019-11-07
Compositions And Methods For The Expansion Of Hematopoietic Stem And Progenitor Cells
App 20190314407 - BOITANO; Anthony ;   et al.
2019-10-17
Compositions and methods for the depletion of CD137+ cells
Grant 10,434,185 - Hartigan , et al. O
2019-10-08
Dosing Regimens For The Mobilization Of Hematopoietic Stem And Progenitor Cells
App 20190269735 - MORROW; DWIGHT ;   et al.
2019-09-05
Dosing Regimens for the Mobilization of Hematopoietic Stem Cells
App 20190167726 - Morrow; Dwight ;   et al.
2019-06-06
Compositions And Methods For The Depletion Of Cd117+ Cells
App 20190153114 - Pearse; Bradley R. ;   et al.
2019-05-23
Compositions And Methods For The Depletion Of Cd117+ Cells
App 20190144558 - Pearse; Bradley R. ;   et al.
2019-05-16
Compositions And Methods For The Depletion Of Cd137+ Cells
App 20190076548 - Hartigan; Adam ;   et al.
2019-03-14
Compositions And Methods For The Depletion Of Cd137+ Cells
App 20180289832 - Hartigan; Adam ;   et al.
2018-10-11
Dosing regimens for the mobilization of hematopoietic stem cells
Grant 10,058,573 - Morrow , et al. August 28, 2
2018-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed